Drug Shortage Report for TEVA-LEVOCARBIDOPA
Report ID | 19973 |
Drug Identification Number | 02244496 |
Brand name | TEVA-LEVOCARBIDOPA |
Common or Proper name | LEVOCARBIDOPA |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CARBIDOPA LEVODOPA |
Strength(s) | 25MG 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N04BA |
ATC description | DOPAMINERGIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-12-29 |
Estimated end date | 2018-06-05 |
Actual end date | 2018-02-21 |
Shortage status | Resolved |
Updated date | 2018-02-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2018-02-22 | English | Compare |
v13 | 2018-02-21 | French | Compare |
v12 | 2018-02-21 | English | Compare |
v11 | 2018-01-03 | French | Compare |
v10 | 2018-01-03 | English | Compare |
v9 | 2017-11-06 | French | Compare |
v8 | 2017-11-06 | English | Compare |
v7 | 2017-09-19 | French | Compare |
v6 | 2017-09-19 | English | Compare |
v5 | 2017-08-30 | French | Compare |
v4 | 2017-08-30 | English | Compare |
v3 | 2017-08-30 | English | Compare |
v2 | 2017-08-21 | French | Compare |
v1 | 2017-08-21 | English | Compare |
Showing 1 to 14 of 14